Concepedia

Renáta Váraljai

RV

Statistics

Publications

15

Citations

564

H-Index

14

Active since

2013

Affiliations

Deutschen Konsortium für Translationale Krebsforschung(Current)

University of Duisburg-Essen

Essen University Hospital

Heidelberg University

German Cancer Research Center

Renáta Váraljai is an author at Deutschen Konsortium für Translationale Krebsforschung specializing in medicine, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

2013–2024

15

Publications

15

Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells

Renáta Váraljai, Abul Bashar Mir Md. Khademul Islam, Michael L. Beshiri et al. · Genes & Development · 2015 · 76 citations · Full text

Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma

Renáta Váraljai, Lisa Zimmer, Yahya Al-Matary et al. · Nature Cancer · 2023 · 56 citations · Full text

Honokiol is a FOXM1 antagonist

Marianna Halasi, Ben Hitchinson, Binal N. Shah et al. · Cell Death and Disease · 2018 · 54 citations · Full text

Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic Melanoma

Renáta Váraljai, Kilian Wistuba‐Hamprecht, Teofila Seremet et al. · JCO Precision Oncology · 2019 · 51 citations · Full text

Expression of Polycomb Targets Predicts Breast Cancer Prognosis

Alba Jené-Sanz, Renáta Váraljai, Alexandra V. Vilkova et al. · Molecular and Cellular Biology · 2013 · 41 citations · Full text

, , +14

1–5 of 15